SmartCardia

Executive Summary

SmartCardia is a Swiss digital health and medical device company specializing in remote cardiac monitoring. Its flagship product, the SmartCardia 7L Patch, is a wearable patch that provides continuous 7-lead ECG and vital signs monitoring for up to 14 days. Unlike traditional Holter monitors, the patch is waterproof, comfortable, and transmits real-time data to the cloud. The company's AI-powered SaaS platform automatically detects arrhythmias and flags patient deterioration, enabling timely clinical interventions. With cardiovascular diseases remaining a leading cause of death, the demand for non-invasive, long-term monitoring solutions is growing rapidly. SmartCardia's technology addresses the limitations of short-duration monitors and the inefficiency of manual ECG analysis. SmartCardia has positioned itself as a competitive player in the remote cardiac monitoring market, which is projected to exceed $5 billion by 2028. The company's device has received CE marking and is already commercialized in Europe. To drive growth, SmartCardia is seeking FDA clearance for the U.S. market, pursuing strategic partnerships with hospitals and telemedicine providers, and expanding clinical evidence. The combination of hardware, AI software, and real-time analytics creates a compelling value proposition for healthcare systems aiming to reduce costs and improve patient outcomes. If execution continues, SmartCardia could become a leading platform for remote cardiac care.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) Clearance for U.S. Market Entry70% success
• Q4 2026Partnership with a Major U.S. Health System60% success
• Q2 2026Publication of AI Algorithm Validation Study80% success